Propranolol

Generic Name
Propranolol
Brand Names
Hemangeol, Hemangiol, Inderal, Innopran
Drug Type
Small Molecule
Chemical Formula
C16H21NO2
CAS Number
525-66-6
Unique Ingredient Identifier
9Y8NXQ24VQ
Background

Propranolol is a racemic mixture of 2 enantiomers where the S(-)-enantiomer has approximately 100 times the binding affinity for beta adrenergic receptors. Propranolol is used to treat a number of conditions but most commonly is used for hypertension.

Propranolol was granted FDA approval on 13 November 1967.

Indication

Propranolol is indicated to treat hypertension. Propranolol is also indicated to treat angina pectoris due to coronary atherosclerosis, atrial fibrillation, myocardial infarction, migraine, essential tremor, hypertrophic subaortic stenosis, pheochromocytoma, and proliferating infantile hemangioma.

Associated Conditions
Akathisia caused by antipsychotic use, Angina Pectoris, Atrial Fibrillation, Cardiovascular Mortality, Essential Tremor, Gastroesophageal variceal hemorrhage prophylaxis, Hemangiomas, Hypertension, Migraine, Myocardial Infarction, Obstructive Hypertrophic Cardiomyopathy, Performance Anxiety, Pheochromocytoma, Proliferating Infantile Hemangioma, Supraventricular Arrhythmias, Tachyarrhythmia caused by Digitalis intoxication, Tachyarrhythmia caused by catecholamine excess, Thyroid Crisis, Thyrotoxicosis, Tremor caused by lithium, Ventricular Tachycardia (VT)
Associated Therapies
-
Clinical Trials
Related News

TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV

First Posted Date
2016-08-03
Last Posted Date
2016-08-03
Lead Sponsor
Zaibo Jiang
Target Recruit Count
100
Registration Number
NCT02853526
Locations
🇨🇳

Department of Radiology, Guangzhou, Guangdong, China

Influence of Propranolol on Conditioned Pain Modulation

Not Applicable
Completed
Conditions
Healthy Subjects
Interventions
Drug: Placebo
Drug: propranolol
First Posted Date
2016-06-22
Last Posted Date
2017-06-28
Lead Sponsor
Kristian Kjær Petersen
Target Recruit Count
25
Registration Number
NCT02808611
Locations
🇩🇰

Center for Sensory Motor Interaction, Aalborg University, Aalborg East, Denmark

Brief Intervention for OCD Fears

Phase 4
Withdrawn
Conditions
Obsessive-compulsive Disorder
Interventions
Drug: Propanolol
Drug: Placebo
First Posted Date
2016-06-06
Last Posted Date
2023-04-18
Lead Sponsor
New York State Psychiatric Institute
Registration Number
NCT02790710
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

Brief Intervention to Reduce Fear of Public Speaking

Phase 4
Terminated
Conditions
Social Anxiety Disorder
Interventions
Drug: propranolol
Drug: Placebo
First Posted Date
2016-06-06
Last Posted Date
2023-06-07
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
6
Registration Number
NCT02790736
Locations
🇺🇸

New York State Psychiatric Institute, 1051 Riverside Drive, New York, New York, United States

Preventing Recurrent Bleeding After Eradication of Esophageal Varices

Phase 4
Conditions
Esophageal Varices
Interventions
Drug: propranolol
First Posted Date
2016-04-15
Last Posted Date
2016-04-15
Lead Sponsor
Kaohsiung Veterans General Hospital.
Target Recruit Count
212
Registration Number
NCT02740166
Locations
🇨🇳

Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan

Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential Trial by the French Sarcoma Group (GSF/GETO)

Phase 1
Conditions
Angiosarcoma
Interventions
Drug: PROPRANOLOL
First Posted Date
2016-04-11
Last Posted Date
2016-04-11
Lead Sponsor
Assistance Publique Hopitaux De Marseille
Target Recruit Count
24
Registration Number
NCT02732678
Locations
🇫🇷

Assistance Publique Hôpitaux de Marseille, Marseill, France

The Effect of Coadministration of Oral Propranolol to Oxytocin on Induction of Labor

First Posted Date
2016-03-09
Last Posted Date
2016-03-09
Lead Sponsor
Ain Shams Maternity Hospital
Target Recruit Count
242
Registration Number
NCT02702674
Locations
🇪🇬

Ain Shams maternity hospital, Cairo, Egypt

To Study the Effect of Nonselective Beta Blockers in Advanced Stage Liver Disease With Ascites

First Posted Date
2016-01-07
Last Posted Date
2023-05-09
Lead Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Target Recruit Count
190
Registration Number
NCT02649335
Locations
🇮🇳

Department of Hepatology,Postgraduate Institute of Medical Education and Research, Chandigarh, India

Disruption of Memory Reconsolidating as a Treatment for Panic Disorder

First Posted Date
2015-12-16
Last Posted Date
2015-12-16
Lead Sponsor
VU University of Amsterdam
Target Recruit Count
60
Registration Number
NCT02631694

Propranolol Dose Escalation in Lymphedema in Patients

Phase 2
Terminated
Conditions
Primary Lymphedema
Interventions
Drug: Propranolol
First Posted Date
2015-11-04
Last Posted Date
2021-10-22
Lead Sponsor
Columbia University
Target Recruit Count
1
Registration Number
NCT02595996
Locations
🇺🇸

Columbia University, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy